Moreover, the degradation of Ikaros and Aiolos induced by IMiDs can upregulate the surface expression of CD38 in MM cells, preparing for the antibody-dependent cytotoxicity induced by daratumab in NK cells (Fedele et al., 2018). The gene discussed is CD38; the disease is Miyoshi myopathy.